1-6 of 6
Christopher A. Klebanoff
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract B051: Deletion of the RNA-binding protein PCBP2 sensitizes tumor cells to CD4+ T cell killing

Free
Korbinian N Kropp, Inaki Etxeberria, Smita S Chandran, Fei Yi, Rebecca Nadler, Michael V Gormally, Jahan Rahman, Salima Benbarche, Jeetayu Biswas, Marco V Ruzzo, Ralph Garippa, Omar Abdel-Wahab, Christopher A Klebanoff
Journal: Cancer Immunology Research
Cancer Immunol Res (2025) 13 (2_Supplement): B051.
https://doi.org/10.1158/2326-6074.IO2025-B051
Published: 23 February 2025
View articletitled, Abstract B051: Deletion of the RNA-binding protein PCBP2 sensitizes tumor cells to CD4+ T cell killing
Journal Articles

T-cell Receptor Gene Therapy Clinically Targeting a TP53 Public Neoantigen

Available to Purchase
Christopher A. Klebanoff
Journal: Cancer Immunology Research
Cancer Immunol Res (2022) 10 (8): 919.
https://doi.org/10.1158/2326-6066.CIR-22-0386
Published: 03 August 2022
View articletitled, T-cell Receptor Gene Therapy Clinically Targeting a TP53 Public Neoantigen
Open the PDF for T-cell Receptor Gene Therapy Clinically Targeting a TP53 Public Neoantigen in another window
Journal Articles

Optimization of T-cell Receptor–Modified T Cells for Cancer Therapy

Free
Dylan J. Drakes, Sarwish Rafiq, Terence J. Purdon, Andrea V. Lopez, Smita S. Chandran, Christopher A. Klebanoff, Renier J. Brentjens
Journal: Cancer Immunology Research
Series: Author Choice
Cancer Immunol Res (2020) 8 (6): 743–755.
https://doi.org/10.1158/2326-6066.CIR-19-0910
Published: 01 June 2020
View articletitled, Optimization of T-cell Receptor–Modified T Cells for Cancer Therapy
Open the PDF for Optimization of T-cell Receptor–Modified T Cells for Cancer Therapy in another window
Includes: Supplementary data
Journal Articles

Identification of the Targets of T-cell Receptor Therapeutic Agents and Cells by Use of a High-Throughput Genetic Platform

Available to Purchase
Ron S. Gejman, Heather F. Jones, Martin G. Klatt, Aaron Y. Chang, Claire Y. Oh, Smita S. Chandran, Tatiana Korontsvit, Viktoriya Zakahleva, Tao Dao, Christopher A. Klebanoff, David A. Scheinberg
Journal: Cancer Immunology Research
Cancer Immunol Res (2020) 8 (5): 672–684.
https://doi.org/10.1158/2326-6066.CIR-19-0745
Published: 01 May 2020
View articletitled, Identification of the Targets of T-cell Receptor Therapeutic Agents and Cells by Use of a High-Throughput Genetic Platform
Open the PDF for Identification of the Targets of T-cell Receptor Therapeutic Agents and Cells by Use of a High-Throughput Genetic Platform in another window
Includes: Supplementary data
Journal Articles

Abstract PR05: T-cells engineered to overcome death signaling within the tumor microenvironment enhance adoptive cancer immunotherapy

Free
Christopher A. Klebanoff
Journal: Cancer Immunology Research
Cancer Immunol Res (2019) 7 (2_Supplement): PR05.
https://doi.org/10.1158/2326-6074.CRICIMTEATIAACR18-PR05
Published: 01 February 2019
View articletitled, Abstract PR05: T-cells engineered to overcome death signaling within the tumor microenvironment enhance adoptive cancer immunotherapy
Journal Articles

Type I Cytokines Synergize with Oncogene Inhibition to Induce Tumor Growth Arrest

Free
Nicolas Acquavella, David Clever, Zhiya Yu, Melody Roelke-Parker, Douglas C. Palmer, Liqiang Xi, Holger Pflicke, Yun Ji, Alena Gros, Ken-ichi Hanada, Ian S. Goldlust, Gautam U. Mehta, Christopher A. Klebanoff, Joseph G. Crompton, Madhusudhanan Sukumar, James J. Morrow, Zulmarie Franco, Luca Gattinoni, Hui Liu, Ena Wang, Francesco Marincola, David F. Stroncek, Chyi-Chia R. Lee, Mark Raffeld, Marcus W. Bosenberg, Rahul Roychoudhuri, Nicholas P. Restifo
Journal: Cancer Immunology Research
Cancer Immunol Res (2015) 3 (1): 37–47.
https://doi.org/10.1158/2326-6066.CIR-14-0122
Published: 06 January 2015
View articletitled, Type I Cytokines Synergize with Oncogene Inhibition to Induce Tumor Growth Arrest
Open the PDF for Type I Cytokines Synergize with Oncogene Inhibition to Induce Tumor Growth Arrest in another window
Includes: Supplementary data